安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Small Cell Lung Cancer Clinical Trials
The clinical trials on this list are for small cell lung cancer All trials on the list are NCI-supported clinical trials, which are sponsored or otherwise financially supported by NCI NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out Clinical trials look at new ways to
- Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research
This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L
- Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
A phase 1 dose-exploration trial of tarlatamab in patients with previously treated small-cell lung cancer showed encouraging antitumor activity, with a median duration of response of 12 3 months
- Treatments in Clinical Trials for Small Cell Lung Cancer - Healthline
Clinical Trials and New Treatments for Small Cell Lung Cancer Medically reviewed by Sheel Patel, MD — Written by Daniel Yetman on November 1, 2024 Recently approved treatments
- Lung Cancer Clinical Trials Research - Memorial Sloan Kettering . . .
We are also conducting a number of clinical trials to test the effectiveness of genomics in treating non-small cell lung cancer If the molecular makeup of your tumor matches certain eligibility criteria, your doctor may offer you the opportunity to participate in the study Our experts can help determine which clinical trials are right for you
- Small cell lung cancer - Cancer Research UK
Read more about A trial of chemoradiotherapy, pembrolizumab, and olaparib for small cell lung cancer (KEYLYNK-013) A trial of MK-7684A and chemotherapy for small cell lung cancer (KeyVibe-008) This trial is looking at a new drug called MK-7684A with chemotherapy to treat small cell lung cancer
- Small Cell Lung Cancer (SCLC) | LUNGevity Foundation
In addition to the approved treatments described above, researchers are testing several new types of treatment in clinical trials for people with small cell lung cancer, including targeted therapy and immunotherapy treatments among others 20 Clinical trials are considered a good option for small cell lung cancer patients, per NCCN guidelines
- Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on . . .
Findings In this randomized clinical trial that included 585 patients with extensive-stage small cell lung cancer who had not previously received systemic therapy, serplulimab plus chemotherapy, compared with placebo plus chemotherapy, significantly improved overall survival (15 4 months vs 10 9 months, respectively; hazard ratio for death, 0 63)
|
|
|